Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | February 28, 2023 08:57am

Gainers

  • Catalyst Biosciences Inc (NASDAQ:CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire 3 programs related to the orphan hematology disorders.
  • Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 40.3% to $1.74 in pre-market trading after the company announced plans to develop advanced smart home security devices.
  • Obseva SA (NASDAQ:OBSV) shares rose 24.4% to $0.12 in pre-market trading after gaining over 16% on Monday. ObsEva announced strategic reorganization to consolidate operations in Switzerland.
  • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) rose 23.1% to $0.3244 in pre-market trading. Adamis Pharmaceuticals and DMK Pharmaceuticals announced agreement and plan of merger.
  • Mount Rainier Acquisition Corp (NASDAQ:RNER) rose 19.8% to $6.05 in pre-market trading. Mount Rainier Acquisition shares dropped 46% on Monday possibly after the company's general meeting was cancelled on Sunday.
  • Lion Group Holding Ltd. (NASDAQ:LGHL) rose 15.9% to $0.40 in pre-market trading after dropping 10% on Monday.
  • Progyny Inc (NASDAQ:PGNY) shares rose 14.6% to $35.62 in pre-market trading after the company reported better-than-expected Q4 results.
  • AIM ImmunoTech Inc (NYSE:AIM) rose 14.6% to $0.55 in pre-market trading after dropping over 7% on Monday. AIM ImmunoTech, last month, entered into a sponsored collaborative clinical research agreement with Erasmus MC and AstraZeneca.
  • Ocugen Inc (NASDAQ:OCGN) rose 11.7% to $1.09 in pre-market trading. Ocugen announced submission of investigational new drug application with the FDA to initiate Phase 1 clinical trial evaluating OCU200 for the treatment of diabetic macular edema.
  • Smart for Life Inc (NASDAQ:SMFL) shares rose 10.5% to $0.21 in pre-market trading after gaining over 7% on Monday.

Losers

  • Aptinyx Inc (NASDAQ:APTX) shares fell 63.6% to $0.22 in pre-market trading after the company reported results from Phase 2 study of NYX-458 in cognitive impairment associated with Parkinson's disease and dementia with lewy bodies and issued pipeline and corporate update.
  • Verde Clean Fuels Inc (NASDAQ:VGAS) fell 18.8% to $10.00 in pre-market after dropping around 17% on Monday.
  • Adapthealth Corp (NASDAQ:AHCO) fell 18.3% to $17.95 in pre-market trading after the company posted a loss for the fourth quarter.
  • Lucira Health Inc (NASDAQ:LHDX) fell 14.7% to $0.43 in pre-market trading. Lucira Health shares jumped 264% on Monday after the company announced FDA authorization for its at-home combination COVID-19 & flu test.
  • Sera Prognostics Inc (NASDAQ:SERA) shares dropped 13.9% to $3.40 in pre-market trading after jumping 18% on Monday. The company recently announced top-line data from the AVERT PRETERM TRIAL.
  • NewtekOne Inc (NASDAQ:NEWT) fell 12.8% to $16.80 in pre-market trading following weaker-than-expected Q4 results.
  • COMSovereign Holding Corp (NASDAQ:COMS) fell 7.6% to $3.39 in pre-market trading after gaining around 10% on Monday. COMSovereign recently announced an 80% year-over-year reduction of outstanding secured debt.
  • Performance Shipping Inc (NASDAQ:PSHG) fell 7.4% to $2.50 in pre-market trading. Performance Shipping announced termination of at-the-market offering.
  • Smith Micro Software, Inc. (NASDAQ:SMSI) shares fell 6.9% to $1.48 in pre-market trading. Smith Micro Software shares dropped 36% on Monday after the company announced it received written notice of contract termination from a U.S.-based Tier 1 carrier customer for the company's family safety solution.
  • Milestone Scientific Inc (NYSE:MLSS) fell 6.4% to $0.71 in pre-market trading after surging 18% on Monday. Milestone Scientific announced 510(k) FDA clearance for the use of CompuFlo® Epidural System in thoracic indications.

Now Read This: Wall Street's Most Accurate Analysts Say Hold These 3 Tech Stocks Delivering High-Dividend Yields

Posted In: ADMP AHCO AIM APTX CBIO COMS ILAG LGHL LHDX MLSS NEWT OBSV OCGN PGNY PSHG RNER SERA SMFL SMSI VGAS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist